By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








Company News
Repros Therapeutics (RPRX) Announces The Issuance Of New U.S. Patent Relating To Treatment Using Off Drug Intervals For Certain Uterine Conditions 4/17/2017 8:07:54 AM
Repros Therapeutics (RPRX) Release: Company Holds Meeting With FDA To Discuss Oral Proellex In The Treatment Of Uterine Fibroids 4/10/2017 9:21:51 AM
Repros Therapeutics (RPRX) Names Larry Dillaha, M.D., Its Permanent President And CEO 4/10/2017 9:13:52 AM
Repros Therapeutics (RPRX) Reports Fourth Quarter And Year End 2016 Financial Results 3/31/2017 6:57:21 AM
Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named 2/2/2017 8:09:36 AM
Repros Therapeutics (RPRX) Release: FDA Grants End Of Phase 2 Meeting To Discuss Phase 3 Requirements For Oral Proellex In The Treatment Of Uterine Fibroids 1/31/2017 8:42:23 AM
Repros Therapeutics (RPRX) Requests Meeting With FDA To Discuss Phase 3 Requirements For Proellex In The Treatment Of Endometriosis 12/20/2016 10:02:45 AM
Repros Therapeutics (RPRX) Requests Meeting With FDA To Discuss Phase III Requirements For Proellex In The Treatment Of Symptomatic Uterine Fibroids 12/13/2016 7:48:59 AM
Repros Therapeutics (RPRX) Release: FDA Advisory Committee Discusses Clinical Trial Designs for Obesity-Related Hypogonadism 12/7/2016 8:08:26 AM
Repros Therapeutics (RPRX) Reports Topline Positive Clinical Data After Two 18 Week Courses Of Proellex Delivered Orally And Vaginally For The Treatment Of Uterine Fibroids 11/15/2016 10:47:15 AM
12345678910...
//-->